Today is

Department of

Pharmacology & Systems Physiology 

Photo of  Andrew Norman, PhD

Andrew Norman, PhD

Professor of Pharmacology

Education/Credentials
  • Doctorate: King's College London
  • Bachelor: King's College London

Contact Information
  • Cardiovascular Building 5938
  • 231 Albert Sabin Way
  • Cincinnati, Ohio 45267-0575
  • Office (513) 558-6654
  • Email andrew.norman@uc.edu

Peer Reviewed Publications

Display All

Kirley, Terence L; Greis, Kenneth D; Norman, Andrew B 2018. Domain unfolding of monoclonal antibody fragments revealed by non-reducing SDS-PAGE. Biochemistry and biophysics reports, 16 , 138-144

Webster, Rose P; Cohen, Cinder F; Saeed, Fatima O; Wetzel, Hanna N; Ball, William J; Kirley, Terence L; Norman, Andrew B 2018. Evaluation of methods to reduce background using the Python-based ELISA_QC program. Journal of immunological methods, 456 , 61-66

Kirley, Terence L; Norman, Andrew B 2015. Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment. Human vaccines & immunotherapeutics, , 0

Norman, Andrew B; Gooden, Felicia C T; Tabet, Michael R; Ball, William J 2014. A Recombinant Humanized Anti-cocaine Monoclonal Antibody Inhibits the Distribution of Cocaine to the Brain in Rats. Drug metabolism and disposition: the biological fate of chemicals, ,

Norman, Andrew B; Tabet, Michael R; Norman, Mantana K; Tsibulsky, Vladimir L 2014. Maintained cocaine self-administration is determined by quantal responses: implications for the measurement of antagonist potency. The Journal of pharmacology and experimental therapeutics, 348 2, 311-5

Wetzel, Hanna N; Tabet, Michael R; Ball, William J; Norman, Andrew B 2014. The effects of a humanized recombinant anti-cocaine monoclonal antibody on the disposition of cocaethylene in mice. International immunopharmacology, 23 2, 387-90

Norman, Andrew B; Ball, William J 2012. Predicting the clinical efficacy and potential adverse effects of a humanized anticocaine monoclonal antibody. Immunotherapy, 4 3, 335-43

Norman, Andrew B; Tabet, Michael R; Norman, Mantana K; Fey, Brittney K; Tsibulsky, Vladimir L; Millard, Ronald W 2011. The affinity of D2-like dopamine receptor antagonists determines the time to maximal effect on cocaine self-administration. The Journal of pharmacology and experimental therapeutics, 338 2, 724-8

Norman, Andrew B; Tabet, Michael R; Norman, Mantana K; Tsibulsky, Vladimir L 2011. Using the self-administration of apomorphine and cocaine to measure the pharmacodynamic potencies and pharmacokinetics of competitive dopamine receptor antagonists. Journal of neuroscience methods, 194 2, 252-8

Norman, Andrew B; Norman, Mantana K; Tabet, Michael R; Tsibulsky, Vladimir L; Pesce, Amadeo J 2010. Competitive dopamine receptor antagonists increase the equiactive cocaine concentration during self-administration. Synapse (New York, N.Y.), ,

Norman, Andrew B; Norman, Mantana K; Buesing, William R; Tabet, Michael R; Tsibulsky, Vladimir L; Ball, William J 2009. The effect of a chimeric human/murine anti-cocaine monoclonal antibody on cocaine self-administration in rats. The Journal of pharmacology and experimental therapeutics, 328 3, 873-81

Thompson, Valerie B; Heiman, Justin; Chambers, James B; Benoit, Stephen C; Buesing, William R; Norman, Mantana K; Norman, Andrew B; Lipton, Jack W 2009. Long-term behavioral consequences of prenatal MDMA exposure. Physiology & behavior, 96 4-5, 593-601

Norman, Andrew B; Tabet, Michael R; Norman, Mantana K; Buesing, William R; Pesce, Amadeo J; Ball, William J 2007. A chimeric human/murine anticocaine monoclonal antibody inhibits the distribution of cocaine to the brain in mice. The Journal of pharmacology and experimental therapeutics, 320 1, 145-53

Tsibulsky, Vladimir L; Norman, Andrew B 2007. Mathematical models of behavior of individual animals. Current pharmaceutical design, 13 15, 1571-95

Norman, Andrew B; Tsibulsky, Vladimir L 2006. The compulsion zone: a pharmacological theory of acquired cocaine self-administration. Brain research, 1116 1, 143-52

Tsibulsky, Vladimir L; Norman, Andrew B 2005. Real time computation of in vivo drug levels during drug self-administration experiments. Brain research. Brain research protocols, 15 1, 38-45

Norman, Andrew B; Buesing, William R; Norman, Mantana K; Tabet, Michael R; Tsibulsky, Vladimir L 2004. The self-administration of WIN 35,428 and cocaine: comparisons of satiety threshold and elimination half-life in rats. European journal of pharmacology, 483 2-3, 281-7

Paula, Stefan; Tabet, Michael R; Farr, Carol D; Norman, Andrew B; Ball, W James 2004. Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody. Journal of medicinal chemistry, 47 1, 133-42

Sutliff, Roy L; Haase, Chad; Russ, Rodney; Hoit, Brian D; Morris, Randal; Norman, Andrew B; Lewis, William 2003. Cocaine increases mortality and cardiac mass in a murine transgenic model of acquired immune deficiency syndrome. Laboratory investigation; a journal of technical methods and pathology, 83 7, 983-9

Norman, Andrew B; Welge, Jeffrey A; Tsibulsky, Vladimir L 2002. Characterization of the distribution of the cocaine priming threshold and the effect of SCH23390. Brain research, 946 2, 253-61

Greis K.; Kirley T.; Norman A. 12-01-2018. Domain unfolding of monoclonal antibody fragments revealed by non-reducing SDS-PAGE Biochemistry and Biophysics Reports, 16 , 138-144

Cabovska B.; Norman A.; Stalcup A. 12-01-2003. Separation of cocaine stereoisomers by capillary electrophoresis using sulfated cyclodextrins Analytical and Bioanalytical Chemistry, 376 1, 134-137

Creese I.; Norman A. 12-01-1986. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on pu Molecular Pharmacology, 30 2, 96-103

Norman A.; Pratt R.; Samaratunga R.; Sanberg P.; Thomas S. 11-27-1989. A magnetic resonance imaging contrast agent differentiates between the vascular properties of fetal Brain Research, 503 1, 156-159

Greis K.; Kirley T.; Norman A. 11-25-2016. Selective disulfide reduction for labeling and enhancement of Fab antibody fragments Biochemical and Biophysical Research Communications, 480 4, 752-757

Aebischer P.; Amisetti S.; Cahill D.; Emerich D.; Koutouzis T.; Norman A.; Ouellette W.; Sanberg P. 11-19-1993. Substance P containing polymer implants protect against striatal excitotoxicity Brain Research, 628 1-2, 327-329

Battaglia G.; Creese I.; Loy R.; Morrow A.; Norman A. 11-18-1985. UP-regulation of serotonergic binding sites labeled by [<sup>3</sup>H]WB4101 following f Life Sciences, 37 20, 1913-1922

Anthenelli R.; Baker D.; Friedman L.; Geracioti T.; Goldsmith R.; Kasckow J.; Keck P.; Norman A.; Richtand N.; Somoza E. 11-17-1997. Cerebrospinal fluid neuroendocrinology of alcohol misusers Addiction Biology, 2 4, 401-409

Battaglia G.; Creese I.; Morrow A.; Norman A. 11-13-1984. [<sup>3</sup>H]WB4101 labels S<inf>1</inf> serotonin receptors in rat cerebr European Journal of Pharmacology, 106 2, 461-462

Norman A.; Tsibulsky V.; Wetzel H. 11-01-2016. The effects of a repeated dose of a recombinant humanized anti-cocaine monoclonal antibody on cocain Drug and Alcohol Dependence, 168 , 287-292

Lu S.; Norgren R.; Norman A.; Pratt R.; Thomas S. 10-30-1992. Magnetic resonance imaging of neural transplants in rat brain using a superparamagnetic contrast age Brain Research, 594 2, 279-283

Blaker S.; Creese I.; Norman A.; Thal L. 10-08-1986. Effects of aging and cholinergic deafferentation on putative muscarinic cholinergic receptor subtype Neuroscience Letters, 70 2, 289-294

Bunsey M.; Giordano M.; Norman A.; Sanberg P. 10-01-1988. The Catalepsy Test: Its Ups and Downs Behavioral Neuroscience, 102 5, 748-759

Norman A.; Tsibulsky V. 09-27-2001. Satiety threshold regulates maintained self-administration: Comment on Lynch and Carroll (2001) Experimental and Clinical Psychopharmacology, 9 2, 151-154

Battaglia G.; Creese I.; Hess E.; Norman A. 09-12-1986. Functional recovery of D<inf>1</inf>dopamine receptor-mediated stimulation of rat striat Neuroscience Letters, 69 3, 290-295

Koster N.; Nickell W.; Norman A.; Pixley S.; Puche A.; Richtand N.; Shipley M. 09-06-1999. Olfactory receptor neurons express D2 dopamine receptors Journal of Comparative Neurology, 411 4, 666-673

Kirley T.; Norman A. 09-05-2018. Unfolding of IgG domains detected by non-reducing SDS-PAGE Biochemical and Biophysical Research Communications, 503 2, 944-949

Cohen C.; Norman A.; Webster R.; Wetzel H. 09-01-2017. A novel Python program for implementation of quality control in the ELISA Journal of Immunological Methods, 448 , 80-84

Norman A.; Wetzel H.; Zhang T. 09-01-2017. A mathematical model of a recombinant humanized anti-cocaine monoclonal antibody's effects on cocain Life Sciences, 184 , 81-86

Battaglia G.; Creese I.; Hess E.; Norman A. 08-30-1985. D<inf>2</inf>dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyc Neuroscience Letters, 59 2, 177-182

Greis K.; Kirley T.; Norman A. 08-26-2016. Structural characterization of expressed monoclonal antibodies by single sample mass spectral analys Biochemical and Biophysical Research Communications, 477 3, 363-368

Norman A.; Tsibulsky V. 08-21-1999. Satiety threshold: A quantitative model of maintained cocaine self- administration Brain Research, 839 1, 85-93

Norman A.; Prince A.; Wylie G. 08-21-1987. Supersensitivity of d-amphetamine-induced hyperthermia in rats following continuous treatment with n European Journal of Pharmacology, 140 3, 349-351

Baker D.; Daniels J.; Norman A. 07-16-1996. Cocaine-induced tics in untreated Tourette's syndrome [1] American Journal of Psychiatry, 153 SUPPL., 965

Dalia A.; Norman A.; Norman M.; Schlueter K.; Tabet M.; Tsibulsky V. 06-22-1998. Transient amelioration of the sensitization of cocaine-induced behaviors in rats by the induction of Brain Research, 797 1, 29-34

Hall J.; Norman A.; Norman M.; Tsibulsky V. 06-12-1999. Priming threshold: A novel quantitative measure of the reinstatement of cocaine self-administration Brain Research, 831 1-2, 165-174

Ball W.; Kirley T.; Norman A.; Saeed F.; Webster R.; Wetzel H. 06-03-2017. Characterization of a recombinant humanized anti-cocaine monoclonal antibody produced from multiple Biochemical and Biophysical Research Communications, 487 3, 690-694

Norman A.; Warner A. 06-01-2000. Mechanisms of cocaine hydrolysis and metabolism in vitro and in vivo: A clarification Therapeutic Drug Monitoring, 22 3, 266-270

Calderon S.; Norman A.; Sanberg P. 05-31-1988. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy Brain Research, 450 1-2, 403-407

Ball W.; Cohen C.; Kirley T.; Norman A.; Saeed F.; Webster R.; Wetzel H. 05-01-2018. Evaluation of methods to reduce background using the Python-based ELISA_QC program Journal of Immunological Methods, 456 , 61-66

Cirino P.; Fogelson M.; King J.; McConville B.; Norman A.; Parker K.; Sanberg P. 04-15-1992. The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in redu Biological Psychiatry, 31 8, 832-840

Norman A.; Pratt R.; Samaratunga R.; Sanberg P.; Thomas S. 03-27-1989. Magnetic resonance imaging of rat brain following kainic acid-induced lesions and fetal striatal tis Brain Research, 483 1, 188-191

Lehman M.; Norman A.; Strother W. 03-12-1998. D1-dopamine receptor binding and tyrosine hydroxylase-immunoreactivity in the fetal and neonatal ham Developmental Brain Research, 106 1-2, 137-144

Fogelson H.; Manderscheid P.; Mcconville B.; Norman A.; Parker K.; Sanberg P. 03-12-1988. NICOTINE GUM AND HALOPERIDOL IN TOURETTE'S SYNDROME The Lancet, 331 8585, 592

Erenberg G.; Fogelson M.; McConville B.; Norman A. 03-05-1994. Sequential use of opioid antagonists and agonists In Tourette's syndrome The Lancet, 343 8897, 601

Amlal H.; Amlal S.; Marckel J.; Norman A.; Wetzel H. 03-01-2019. A Recombinant Humanized Anticocaine Monoclonal Antibody Alters the Urinary Clearance of Cocaine and Drug metabolism and disposition: the biological fate of chemicals, 47 3, 184-188

Norman A.; Sanberg P. 03-01-1989. Underrecognized and underresearched side effects of neuroleptics. American Journal of Psychiatry, 146 3, 411-412

Khosla U.; Klug J.; Norman A.; Thompson H. 02-28-1994. Autoradiographic measurement of tyrosine hydroxylase immunoreactivity in rat brain using enhanced ch Brain Research, 638 1-2, 352-356

Battaglia G.; Creese I.; Morrow A.; Norman A. 02-26-1985. Identification of subtypes of [<sup>3</sup>H]prazosin-labelled ?<inf>1</inf> European Journal of Pharmacology, 109 2, 285-287

Ford L.; Kolmonpunporn M.; Norman A.; Sanberg P. 02-13-1990. Chronic treatment with MK-801 increases the quinolinic acid-induced loss of D-1 dopamine receptors i European Journal of Pharmacology, 176 3, 363-366

Norman A.; Tsibulsky V. 02-12-2001. Satiety threshold during maintained cocaine self-administration in outbred mice NeuroReport, 12 2, 325-328

Klug J.; Lu S.; Norgren R.; Norman A. 02-12-1993. Sensitization of c-fos expression in rat striatum following multiple challenges with d-amphetamine Brain Research, 603 1, 125-128

Battaglia G.; Creese I.; Hess E.; Iorio L.; Norman A. 02-11-1986. Guanine nucleotide regulation of agonist interactions at [<sup>3</sup>H]SCH23390-labeled European Journal of Pharmacology, 121 1, 31-38

Ball W.; Norman A.; Tabet M.; Wetzel H. 02-01-2016. Erratum: The effects of a humanized recombinant anti-cocaine monoclonal antibody on the disposition International Immunopharmacology, 31 , 272-273

Battaglia G.; Creese I.; Norman A. 01-19-1988. Age-related differential recovery rates of rat striatal D-1 dopamine receptors following irreversibl European Journal of Pharmacology, 145 3, 281-290

Hildebrand J.; Norgren R.; Norman A.; Sanberg P.; Wyatt L. 01-08-1992. The direction of apomorphine-induced rotation behavior is dependent on the location of excitotoxin i Brain Research, 569 1, 169-172

Norman A.; Tsibulsky V. 01-01-2012. Simple deterministic mathematical model of maintained drug self-administration behavior and its phar Computational Neuroscience of Drug Addiction, , 3-18

Baker D.; Ekhator N.; Geracioti T.; Hill K.; Keck P.; Norman A.; West S.; Wortman M. 01-01-1999. Low CSF concentration of a dopamine metabolite in tobacco smokers American Journal of Psychiatry, 156 1, 130-132

Keck J.; McCorville B.; Norman A.; Pagnucco M.; Shapira N. 01-01-1997. Novel uyse of tramadol hydrochloride in the treatment of Tourette's syndrome [2] Journal of Clinical Psychiatry, 58 4, 174-175

Bertram K.; Ennis M.; Norman A.; Sanberg P.; Shipley M. 01-01-1994. Permeability of the blood-brain barrier within rat intrastriatal transplants assessed by simultaneou Experimental Neurology, 127 2, 245-252

Cahill D.; El-Etri M.; Emerich D.; Norman A.; Sanberg P.; Shipley M.; Zanol M. 01-01-1993. Nicotine potentiation of haloperidol-induced catalepsy: Striatal mechanisms Pharmacology, Biochemistry and Behavior, 46 2, 303-307

Cahill D.; Freeman T.; Koutouzis T.; Norman A.; Sanberg P. 01-01-1993. Behavioral effects of fetal neural transplants: Relevance to Huntington's disease Brain Research Bulletin, 32 5, 493-496

Emerich D.; Lehman M.; Lu S.; Norman A.; Pixley S. 01-01-1993. Effect of Fetal Striatal and Astrocyte Transplants into Unilateral Excitotoxin-Lesioned Striatum Journal of Neural Transplantation and Plasticity, 4 4, 279-287

Klug J.; Norman A. 01-01-1993. Long-term sensitization of apomorphine-induced rotation behavior in rats with dopamine deafferentati Pharmacology, Biochemistry and Behavior, 46 2, 397-403

Lu S.; Norman A. 01-01-1993. Neurotransmitter Receptors in Fetal Tissue Transplants: Expression and Functional Significance Journal of Neural Transplantation and Plasticity, 4 3, 215-226

Arevalo E.; Bronheim S.; Licamele W.; McConville B.; Norman A.; Rickards E.; Sonnenschein K. 01-01-1992. Nicotine gum in Tourette's disorder [15] American Journal of Psychiatry, 149 3, 417-418

Bertram K.; Norman A.; Pratt R.; Samaratunga R.; Sanberg P.; Thomas S. 01-01-1991. Magnetic resonance imaging of rat brain following in vivo disruption of the cerebral vasculature Brain Research Bulletin, 26 4, 593-597

Emerich D.; Joyce J.; Norman A.; Sanberg P. 01-01-1991. Regulation and Assessment of Receptors following Transplants Methods in Neurosciences, 7 C, 456-477

Emerich D.; McConville B.; Norman A.; Sanberg P.; Zanol M. 01-01-1991. Nicotine potentiates haloperidol-induced catalepsy and locomotor hypoactivity Pharmacology, Biochemistry and Behavior, 38 4, 875-880

Emerich D.; Norman A.; Sanberg P. 01-01-1991. Nicotine potentiates the behavioral effects of haloperidol Psychopharmacology Bulletin, 27 3, 385-390

Emerich D.; Norman A.; Sanberg P.; Shipley M.; Zubricki E. 01-01-1991. Female rats are more sensitive to the locomotor alterations following quinolinic acid-induced striat Experimental Neurology, 111 3, 369-378

Fogelson M.; Klykylo W.; Manderscheid P.; McConville B.; Norman A.; Parker K.; Sanberg P. 01-01-1991. Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder American Journal of Psychiatry, 148 6, 793-794

Ford L.; Norman A.; Sanberg P. 01-01-1991. Differential loss of neurochemical markers following quinolinic acid-induced lesions of rat striatum Experimental Neurology, 114 1, 132-135

Kaplan S.; Nash D.; Norman A.; Sanberg P. 01-01-1991. An evaluation of the possible protective effects of neonatal striatal transplants against kainic aci Journal of Neural Transplantation and Plasticity, 2 1, 75-79

Kaplan S.; Norman A.; Sanberg P. 01-01-1991. AN Evaluation of the Possible Protective Effects of Neonatal Striatal Transplants Against Kainic Aci Journal of Neural Transplantation, 2 1, 75-79

Lu S.; Norman A.; Sanberg P.; Shipley M. 01-01-1991. Striatal, ventral mesencephalic and cortical transplants into the intact rat striatum: A neuroanatom Experimental Neurology, 113 2, 109-130

Nickell W.; Norman A.; Shipley M.; Wyatt L. 01-01-1991. Olfactory bulb DA receptors may be located on terminals of the olfactory nerve NeuroReport, 2 1, 9-12

Norman A.; Pratt R.; Samaratunga R.; Sanberg P.; Thomas S. 01-01-1991. Magnetic Resonance Imaging of Rat Brain to Assess Kainic Acid-Induced Lesions and Transplants Methods in Neurosciences, 7 C, 408-428

Brauckmann J.; Ford L.; Giordano M.; Norman A.; Sanberg P. 01-01-1990. MK801 prevents quinolinic acid-induced behavioral deficits and neurotoxicity in the striatum Brain Research Bulletin, 24 3, 313-319

Dreshfield L.; Giordano M.; Moody C.; Norman A.; Sanberg P.; Zubrycki E. 01-01-1990. Prenatal exposure to cocaine in rats: Lack of long-term effects on locomotion and stereotypy Bulletin of the Psychonomic Society, 28 1, 51-54

Giordano M.; Lu S.; Norman A.; Sanberg P.; Shipley M. 01-01-1990. Behavioral effects of neural transplants into the intact striatum Pharmacology, Biochemistry and Behavior, 37 1, 135-148

Hildebrand J.; Kolmonpunporn M.; Lehman M.; Moody C.; Norman A.; Sanberg P.; Wyatt L. 01-01-1990. Sensitization of rotation behavior in rats with unilateral 6-hydroxydopamine or kainic acid-induced Pharmacology, Biochemistry and Behavior, 37 4, 755-759

Lu S.; Norman A.; Ragozzino M.; Sanberg P.; Shipley M.; Zubrycki E. 01-01-1990. NADPH-Diaphorase-containing neurons and cytochrome oxidase activity following striatal quinolinic ac Progress in Brain Research, 82 C, 427-431

Norman A.; Pratt R.; Samaratunga R.; Sanberg P.; Thomas S. 01-01-1990. T1 and T2 weighted magnetic resonance imaging of excitotoxin lesions and neural transplants in rat b Experimental Neurology, 109 2, 164-170

B. Norman A.; Calderon S.; El-etri M.; Sanberg P.; Shipley M.; Weissman E.; Zubrycki E. 01-01-1989. The effect of prenatal treatment with MPTP or MPP<sup>+</sup> on the development of dopa Pharmacology, Biochemistry and Behavior, 34 3, 545-551

Blythe M.; Fogelson H.; Klykylo W.; Manderscheid P.; McConville B.; Norman A.; Parker K.; Sanberg P. 01-01-1989. Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome Biomedicine and Pharmacotherapy, 43 1, 19-23

Borchers M.; Norman A.; Price A.; Sanberg P.; Wachendorf T. 01-01-1989. Loss of D<inf>1</inf> and D<inf>2</inf> dopamine receptors and muscarinic ch Brain Research Bulletin, 22 4, 633-636

Calderon S.; Giordano M.; Norman A.; Sanberg P.; Tew J. 01-01-1989. The quinolinic acid model of Huntington's disease: Locomotor abnormalities Experimental Neurology, 105 1, 45-53

Creese I.; Eubanks J.; Norman A. 01-01-1989. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding Journal of Pharmacology and Experimental Therapeutics, 248 3, 1116-1122

Fogelson M.; Ford L.; Norman A.; Sanberg P. 01-01-1989. Mk-801 prevents hippocampal neurodegeneration in neonatal hypoxic-ischemic rats Archives of Neurology, 46 10, 1090-1096

Ford L.; Norman A.; Sanberg P. 01-01-1989. The topography of MK-801-induced locomotor patterns in rats Physiology and Behavior, 46 4, 755-758

Giordano M.; Norman A.; Sanberg P. 01-01-1989. Fetal striatal tissue grafts into excitotoxin-lesioned striatum: Pharmacological and behavioral aspe Pharmacology, Biochemistry and Behavior, 34 1, 139-147

Lehman M.; Norman A.; Sanberg P. 01-01-1989. Functional effects of fetal striatal transplants Brain Research Bulletin, 22 1, 163-172

Manderscheid P.; Montgomery S.; Moss D.; Norman A.; Sanberg P. 01-01-1989. Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of tourette syndrome and othe Life Sciences, 44 21, 1521-1525

Nash D.; Norman A.; Sanberg P. 01-01-1989. [<sup>3</sup>H]lysergic acid diethylamide (LSD): differential agonist and antagonist bin Neurochemistry International, 14 4, 497-504

Norman A.; Sanberg P.; Wachendorf T. 01-01-1989. Differential effect of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on [<sup>3</su Life Sciences, 44 13, 831-836

Calderon S.; Giordano M.; Nash D.; Norman A.; Sanberg P.; Shipley M. 01-01-1988. Neural transplants disrupt the blood-brain barrier and allow peripherally acting drugs to exert a ce Experimental Neurology, 102 1, 149-152

Calderon S.; Giordano M.; Norman A.; Sanberg P. 01-01-1988. A novel rotational behavior model for assessing the restructuring of striatal dopamine effector syst Progress in Brain Research, 78 C, 61-67

Calderon S.; Giordano M.; Norman A.; Sanberg P. 01-01-1988. Striatal tissue transplants attenuate apomorphine-induced rotational behavior in rats with unilatera Neuropharmacology, 27 3, 333-336

Creese I.; Hess E.; Norman A. 01-01-1988. Chronic treatment with dopamine receptor antagonists: Behavioral and pharmacologic effects on D<i Journal of Neuroscience, 8 7, 2361-2370

Norman A.; Sanberg P. 01-01-1988. Adrenal transplants for Huntington's disease? [8] Nature, 335 6186, 122

Battaglia G.; Creese I.; Hess E.; Norman A. 01-01-1987. Differential modification of striatal D<inf>1</inf>dopamine receptors and effector moiet Molecular Pharmacology, 31 1, 50-57

Battaglia G.; Creese I.; Norman A. 01-01-1987. Differential recovery rates of rat D<inf>2</inf> dopamine receptors as a function of agi Journal of Neuroscience, 7 5, 1484-1491

Battaglia G.; Creese I.; Norman A. 01-01-1987. Differential serotonin<inf>2</inf>receptor recovery in mature and senescent rat brain af Journal of Pharmacology and Experimental Therapeutics, 243 1, 69-75

Calderon S.; Garver D.; Norman A.; Sanberg P. 01-01-1987. Brain tissue transplants in an animal model of Huntington's disease Psychopharmacology Bulletin, 23 3, 476-482

Battaglia G.; Creese I.; Hess E.; Norman A. 01-01-1986. Forskolin Potentiates the Stimulation of Rat Striatal Adenylate Cyclase Mediated by D?1 Dopamine Rec Journal of Neurochemistry, 46 4, 1180-1185

Battaglia G.; Creese I.; Newton P.; Norman A. 01-01-1986. In Vitro and In Vivo Irreversible Blockade of Cortical S<inf>2</inf> Serotonin Receptors Journal of Neurochemistry, 46 2, 589-593

Battaglia G.; Creese I.; Norman A. 01-01-1986. Regulation of putative muscarinic cholinergic receptor subtypes in rat brain Neurochemistry International, 9 2, 337-347

Battaglia G.; Creese I.; Norman A. 01-01-1985. Forskolin effects on the stimulatory and inhibitory components of rat striatal adenylate cyclase Federation Proceedings, 44 3,

Battaglia G.; Creese I.; Norman A. 01-01-1985. Properties of<sup>3</sup>H-WB4101-labeled 5HT-1 receptors in rat brain Federation Proceedings, 44 4,

Battaglia G.; Creese I.; Norman A. 01-01-1985. [<sup>3</sup>H]WB4101 labels the 5-HT(1A) serotonin receptor subtype in rat brain. Guani Molecular Pharmacology, 28 6, 487-494